FDA alerts patients and health care professionals of 

EpiPen auto-injector errors related to device malfunctions
and user  administration.
  • FDA is alerting patients, caregivers, and health care professionals that EpiPen 0.3mg and EpiPen Jr 0.15mg 

auto-injectors, and the authorized generic versions, may potentially have delayed injection or be prevented

from properly injecting.

  • Patients should contact Mylan Customer Relations at 800-796-9526 if they find an issue with their 

auto-injector and to obtain a replacement at no additional cost.  FDA is aware of adverse event reports 

associated with EpiPen products.  FDA asks health care professionals and consumers to report any adverse

reactions or quality problems to the FDA's Medwatch program.